BNP Paribas Financial Markets’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $733K | Buy |
78,120
+67,631
| +645% | +$640K | ﹤0.01% | 3523 |
|
|
2026
Q1 | $98.5K | Buy |
10,489
+10,450
| +26,795% | +$88K | ﹤0.01% | 4385 |
|
|
2025
Q4 | $317 | Sell |
39
-475
| -92% | -$5.86K | ﹤0.01% | 5521 |
|
|
2025
Q3 | $6.5K | Sell |
514
-1,742
| -77% | -$16.6K | ﹤0.01% | 5069 |
|
|
2025
Q2 | $15.6K | Sell |
2,256
-1,396
| -38% | -$10.1K | ﹤0.01% | 4708 |
|
|
2025
Q1 | $19.4K | Sell |
3,652
-23,731
| -87% | -$209K | ﹤0.01% | 4544 |
|
|
2024
Q4 | $323K | Buy |
+27,383
| New | +$459K | ﹤0.01% | 3582 |
|
|
2023
Q1 | – | Sell |
-3
| Closed | -$11 | – | 3890 |
|
|
2022
Q4 | $11 | Hold |
3
| – | – | ﹤0.01% | 4003 |
|
|
2022
Q3 | $16 | Hold |
3
| – | – | ﹤0.01% | 4695 |
|
|
2022
Q2 | $25 | Hold |
3
| – | – | ﹤0.01% | 4053 |
|
|
2022
Q1 | $53 | Sell |
3
-7
| -70% | -$93 | ﹤0.01% | 4105 |
|
|
2021
Q4 | $191 | Sell |
10
-98
| -91% | -$2.65K | ﹤0.01% | 4149 |
|
|
2021
Q3 | $3.29K | Sell |
108
-15
| -12% | -$592 | ﹤0.01% | 3746 |
|
|
2021
Q2 | $6.74K | Sell |
123
-226
| -65% | -$12.5K | ﹤0.01% | 3784 |
|
|
2021
Q1 | $20.6K | Sell |
349
-2,040
| -85% | -$134K | ﹤0.01% | 3754 |
|
|
2020
Q4 | $89.6K | Buy |
2,389
+1,737
| +266% | +$64.9K | ﹤0.01% | 3266 |
|
|
2020
Q3 | $35.2K | Buy |
652
+414
| +174% | +$75K | ﹤0.01% | 3622 |
|
|
2020
Q2 | $59.8K | Sell |
238
-398
| -63% | -$80.4K | ﹤0.01% | 2963 |
|
|
2020
Q1 | $100K | Buy |
636
+397
| +166% | +$67.1K | ﹤0.01% | 3209 |
|
|
2019
Q4 | $39.1K | Sell |
239
-68
| -22% | -$10.1K | ﹤0.01% | 3773 |
|
|
2019
Q3 | $44.9K | Buy |
307
+98
| +47% | +$17.1K | ﹤0.01% | 3537 |
|
|
2019
Q2 | $43.5K | Sell |
209
-180
| -46% | -$38.5K | ﹤0.01% | 3505 |
|
|
2019
Q1 | $81.2K | Buy |
389
+388
| +38,800% | +$85.6K | ﹤0.01% | 3247 |
|
|
2018
Q4 | $93 | Sell |
1
-48
| -98% | -$9.58K | ﹤0.01% | 4190 |
|
|
2018
Q3 | $11.2K | Hold |
49
| – | – | ﹤0.01% | 3677 |
|
|
2018
Q2 | $7.47K | Sell |
49
-297
| -86% | -$54K | ﹤0.01% | 3919 |
|
|
2018
Q1 | $63.3K | Sell |
346
-21
| -6% | -$4.72K | ﹤0.01% | 3429 |
|
|
2017
Q4 | $78.1K | Buy |
367
+223
| +155% | +$47.7K | ﹤0.01% | 3438 |
|
|
2017
Q3 | $30.9K | Sell |
144
-11
| -7% | -$2.15K | ﹤0.01% | 3383 |
|
|
2017
Q2 | $29.2K | Buy |
+155
| New | +$30.4K | ﹤0.01% | 3453 |
|
Other funds holding CRBP
VCM
VFT
VPM
BNP Paribas Financial Markets's CRBP Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Corbus Pharmaceuticals (CRBP) stake by 645% in Q2 2026, buying an estimated $640K and bringing the position to 78,120 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #3523.
BNP Paribas Financial Markets first reported a position in CRBP in Q2 2017 and has held it in 30 quarters since. 66 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.
- BNP Paribas Financial Markets held 78,120 shares of Corbus Pharmaceuticals worth $733K as of Q2 2026.
- BNP Paribas Financial Markets bought 67,631 Corbus Pharmaceuticals shares in Q2 2026, an estimated $640K.
- Corbus Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3523 holding.
- BNP Paribas Financial Markets first reported a position in Corbus Pharmaceuticals in Q2 2017 and has held it in 30 quarters since.
- 66 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.